Caribou Biosciences, Inc. (CRBU)

Caribou Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	31.97	51.16	58.34	240.42	15.95	41.07
Short-Term Investments	196.21	277.67	189.33	135.41	-	8.4
Cash & Short-Term Investments	228.18	328.83	247.66	375.83	15.95	49.47
Cash Growth	-32.59%	32.77%	-34.10%	2255.87%	-67.75%	-
Accounts Receivable	0.98	1.57	2.45	2.64	1.48	0.84
Other Receivables	1.68	2.29	2.22	5.48	3.68	3.14
Receivables	2.67	3.86	4.66	8.12	5.16	3.98
Prepaid Expenses	4.38	4.94	6.37	3.85	1.82	1.15
Other Current Assets	2.2	1.22	1.55	3.39	1.38	2.41
Total Current Assets	237.43	338.84	260.25	391.19	24.31	57.01
Property, Plant & Equipment	40.06	40.45	34.91	4.89	3.5	4.33
Long-Term Investments	62.11	51.33	77.07	45.3	7.63	-
Other Long-Term Assets	4.74	1.59	1.54	0.98	0.61	0.59
Total Assets	344.33	432.21	373.77	442.36	36.05	61.93
Accounts Payable	2.7	3.12	1.15	3.99	2.6	2.54
Accrued Expenses	20.56	19.65	14.41	12.09	8.15	5.65
Current Portion of Long-Term Debt	-	-	-	-	0.65	-
Current Portion of Leases	1.18	1.2	0.97	-	-	-
Current Income Taxes Payable	-	-	-	-	-	0.01
Current Unearned Revenue	2.83	2.85	9.94	8.7	0.16	0.72
Other Current Liabilities	4.89	1.48	1.67	1.05	0.82	1.16
Total Current Liabilities	32.16	28.3	28.13	25.83	12.39	10.08
Long-Term Debt	-	-	-	-	0.92	-
Long-Term Leases	25.46	25.91	26.78	-	0.1	0.2
Long-Term Unearned Revenue	3.95	6.1	15.95	22.03	0.94	0.99
Long-Term Deferred Tax Liabilities	0.56	0.56	0.38	0.48	0.16	0.65
Other Long-Term Liabilities	1.01	2.94	1.65	6.19	3.66	1.23
Total Liabilities	63.13	63.81	72.89	54.53	18.16	13.15
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	693.31	667.65	499.6	485.75	7.43	4.03
Retained Earnings	-412.9	-299.29	-197.22	-97.79	-30.87	3.44
Comprehensive Income & Other	0.79	0.03	-1.52	-0.14	-	-
Total Common Equity	281.2	368.4	300.87	387.83	-23.44	7.46
Shareholders' Equity	281.2	368.4	300.87	387.83	17.89	48.79
Total Liabilities & Equity	344.33	432.21	373.77	442.36	36.05	61.93
Total Debt	26.64	27.11	27.75	-	1.68	0.2
Net Cash (Debt)	254.37	345.3	289.29	413.51	14.28	49.27
Net Cash Growth	-31.11%	19.36%	-30.04%	2796.73%	-71.03%	-
Net Cash Per Share	2.84	4.68	4.76	13.06	1.67	5.88
Filing Date Shares Outstanding	90.55	90.31	61.3	60.66	10.39	8.37
Total Common Shares Outstanding	90.55	88.45	61.03	60.26	9.71	8.37
Working Capital	205.27	310.54	232.12	365.36	11.92	46.93
Book Value Per Share	3.11	4.17	4.93	6.44	-2.41	0.89
Tangible Book Value	281.2	368.4	300.87	387.83	-23.44	7.46
Tangible Book Value Per Share	3.11	4.17	4.93	6.44	-2.41	0.89
Machinery	19.88	16.98	13.46	7.25	5.42	5.45
Construction In Progress	-	8.2	0.99	0.01	-	-
Leasehold Improvements	11.49	2.24	1.88	1.7	1.18	1.15

Source: S&P Capital IQ. Standard template. Financial Sources.